OMEROS CORP Increase (Decrease) in Accounts Payable and Accrued Liabilities
OMEROS CORP (OMER) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $1.24 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-12
- OMEROS CORP increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $2.22M, a 73.06% decline year-over-year.
- OMEROS CORP increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$979.00K.
- OMEROS CORP increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$1.75M, a 128.90% decline year-over-year.
- OMEROS CORP increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $3.13M.
- OMEROS CORP increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $4.58M.
- OMEROS CORP increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$5.24M, a 211.90% decline from fiscal 2023.
- OMEROS CORP increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $4.68M.
- OMEROS CORP increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was -$10.66M, a 172.85% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 204 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 207 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $1.24M 10-Q · filed 2026-08-12 | -$510.00K derived: sum of 3 quarters · filed 2026-08-12 | $2.62M derived: sum of 4 quarters · filed 2026-08-12 | ||||||
| 2026-03-31 | -$979.00K 10-Q · filed 2026-05-13 | -$2.73M derived: sum of 2 quarters · filed 2026-05-13 | $398.00K derived: sum of 3 quarters · filed 2026-05-13 | $8.64M derived: sum of 4 quarters · filed 2026-08-12 | ||||||
| 2025-12-31 | -$1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.38M derived: sum of 2 quarters · filed 2026-03-31 | $9.62M derived: sum of 3 quarters · filed 2026-08-12 | $4.58M 10-K · filed 2026-03-31 | ||||||
| 2025-09-30 | $3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $11.38M derived: sum of 2 quarters · filed 2026-08-12 | $6.33M 10-Q · filed 2025-11-13 | $12.40M derived: sum of 4 quarters · filed 2026-08-12 | ||||||
| 2025-06-30 | $8.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $3.21M 10-Q · filed 2026-08-12 | $9.27M derived: sum of 3 quarters · filed 2026-08-12 | $3.63M derived: sum of 4 quarters · filed 2026-08-12 | ||||||
| 2025-03-31 | -$5.04M 10-Q · filed 2026-05-13 | -$4.98M 10-Q · filed 2025-05-15 | $1.02M derived: sum of 2 quarters · filed 2026-05-13 | -$4.62M derived: sum of 3 quarters · filed 2026-05-13 | -$5.28M derived: sum of 4 quarters · filed 2026-05-13 | |||||
| 2024-12-31 | $6.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $425.00K derived: sum of 2 quarters · filed 2026-03-31 | -$242.00K derived: sum of 3 quarters · filed 2026-03-31 | -$5.24M 10-K · filed 2026-03-31 | -$10.78M 10-K · filed 2025-03-31 | |||||
| 2024-09-30 | -$5.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$6.31M derived: sum of 2 quarters · filed 2025-11-13 | -$11.30M 10-Q · filed 2025-11-13 | -$10.36M derived: sum of 4 quarters · filed 2026-03-31 | ||||||
| 2024-06-30 | -$667.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$5.66M 10-Q · filed 2025-08-14 | -$6.38M 10-Q · filed 2024-08-07 | -$4.72M derived: sum of 3 quarters · filed 2026-03-31 | -$3.74M derived: sum of 4 quarters · filed 2026-03-31 | |||||
| 2024-03-31 | -$5.00M 10-Q · filed 2025-05-15 | -$4.06M derived: sum of 2 quarters · filed 2026-03-31 | -$3.07M derived: sum of 3 quarters · filed 2026-03-31 | -$1.05M derived: sum of 4 quarters · filed 2026-03-31 | ||||||
| 2023-12-31 | $941.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.92M derived: sum of 2 quarters · filed 2026-03-31 | $3.95M derived: sum of 3 quarters · filed 2026-03-31 | $4.68M 10-K · filed 2026-03-31 | ||||||
| 2023-09-30 | $982.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $3.01M derived: sum of 2 quarters · filed 2024-11-13 | $3.74M 10-Q · filed 2024-11-13 | $4.62M derived: sum of 4 quarters · filed 2025-03-31 | ||||||
| 2023-06-30 | $2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $2.76M 10-Q · filed 2024-08-07 | $3.64M derived: sum of 3 quarters · filed 2025-03-31 | $4.75M derived: sum of 4 quarters · filed 2025-03-31 | ||||||
| 2023-03-31 | $733.00K 10-Q · filed 2024-05-15 | $1.61M derived: sum of 2 quarters · filed 2025-03-31 | $2.72M derived: sum of 3 quarters · filed 2025-03-31 | $5.74M derived: sum of 4 quarters · filed 2025-03-31 | ||||||
| 2022-12-31 | $879.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.99M derived: sum of 2 quarters · filed 2025-03-31 | $5.01M derived: sum of 3 quarters · filed 2025-03-31 | -$10.66M 10-K · filed 2025-03-31 | ||||||
| 2022-09-30 | $1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $4.13M derived: sum of 2 quarters · filed 2023-11-09 | -$11.54M 10-Q · filed 2023-11-09 | -$1.70M derived: sum of 4 quarters · filed 2024-04-01 | ||||||
| 2022-06-30 | $3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$12.65M 10-Q · filed 2023-08-09 | -$2.81M derived: sum of 3 quarters · filed 2024-04-01 | -$7.88M derived: sum of 4 quarters · filed 2024-04-01 | ||||||
| 2022-03-31 | -$15.67M 10-Q · filed 2023-05-09 | -$5.83M derived: sum of 2 quarters · filed 2024-04-01 | -$10.90M derived: sum of 3 quarters · filed 2024-04-01 | -$7.59M derived: sum of 4 quarters · filed 2024-04-01 | ||||||
| 2021-12-31 | $9.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $4.77M derived: sum of 2 quarters · filed 2024-04-01 | $8.08M derived: sum of 3 quarters · filed 2024-04-01 | $14.64M 10-K · filed 2024-04-01 | ||||||
| 2021-09-30 | -$5.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.77M derived: sum of 2 quarters · filed 2022-11-09 | $4.80M 10-Q · filed 2022-11-09 | -$6.24M derived: sum of 4 quarters · filed 2023-03-13 | ||||||
| 2021-06-30 | $3.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $9.87M 10-Q · filed 2022-08-09 | -$1.17M derived: sum of 3 quarters · filed 2023-03-13 | $8.36M derived: sum of 4 quarters · filed 2023-03-13 | ||||||
| 2021-03-31 | $6.56M 10-Q · filed 2022-05-10 | -$4.47M derived: sum of 2 quarters · filed 2023-03-13 | $5.05M derived: sum of 3 quarters · filed 2023-03-13 | -$15.02M derived: sum of 4 quarters · filed 2023-03-13 | ||||||
| 2020-12-31 | -$11.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$1.51M derived: sum of 2 quarters · filed 2023-03-13 | -$21.58M derived: sum of 3 quarters · filed 2023-03-13 | -$19.74M 10-K · filed 2023-03-13 | ||||||
| 2020-09-30 | $9.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$10.55M derived: sum of 2 quarters · filed 2021-11-09 | -$8.70M 10-Q · filed 2021-11-09 | -$2.34M derived: sum of 4 quarters · filed 2021-11-09 | ||||||
| 2020-06-30 | -$20.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$18.23M 10-Q · filed 2021-08-09 | -$11.86M derived: sum of 3 quarters · filed 2021-08-09 | -$6.79M derived: sum of 4 quarters · filed 2021-08-09 | ||||||
| 2020-03-31 | $1.85M 10-Q · filed 2021-05-10 | $8.21M derived: sum of 2 quarters · filed 2021-05-10 | $13.28M derived: sum of 3 quarters · filed 2021-05-10 | $9.25M derived: sum of 4 quarters · filed 2021-05-10 | ||||||
| 2019-12-31 | $6.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $11.44M derived: sum of 2 quarters · filed 2021-03-01 | $7.40M derived: sum of 3 quarters · filed 2021-03-01 | $13.28M 10-K · filed 2021-03-01 | ||||||
| 2019-09-30 | $5.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.04M derived: sum of 2 quarters · filed 2020-11-09 | $6.92M 10-Q · filed 2020-11-09 | $19.21M derived: sum of 4 quarters · filed 2021-03-01 | ||||||
| 2019-06-30 | -$4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.85M 10-Q · filed 2020-08-10 | $14.14M derived: sum of 3 quarters · filed 2021-03-01 | $14.20M derived: sum of 4 quarters · filed 2021-03-01 | ||||||
| 2019-03-31 | $5.88M 10-Q · filed 2020-05-11 | $18.18M derived: sum of 2 quarters · filed 2021-03-01 | $18.24M derived: sum of 3 quarters · filed 2021-03-01 | $17.83M derived: sum of 4 quarters · filed 2021-03-01 | ||||||
| 2018-12-31 | $12.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $12.36M derived: sum of 2 quarters · filed 2021-03-01 | $11.94M derived: sum of 3 quarters · filed 2021-03-01 | $10.11M 10-K · filed 2021-03-01 | $10.54M 10-K · filed 2019-03-01 | |||||
| 2018-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$348.00K derived: sum of 2 quarters · filed 2019-11-12 | -$2.18M 10-Q · filed 2019-11-12 | -$808.00K derived: sum of 4 quarters · filed 2020-03-02 | ||||||
| 2018-06-30 | -$412.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$2.25M 10-Q · filed 2019-08-08 | -$872.00K derived: sum of 3 quarters · filed 2020-03-02 | -$1.16M derived: sum of 4 quarters · filed 2020-03-02 | ||||||
| 2018-03-31 | -$1.83M 10-Q · filed 2019-05-09 | -$460.00K derived: sum of 2 quarters · filed 2020-03-02 | -$743.00K derived: sum of 3 quarters · filed 2020-03-02 | $6.91M derived: sum of 4 quarters · filed 2020-03-02 | ||||||
| 2017-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.09M derived: sum of 2 quarters · filed 2020-03-02 | $8.75M derived: sum of 3 quarters · filed 2020-03-02 | $9.52M 10-K · filed 2020-03-02 | ||||||
| 2017-09-30 | -$283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $7.37M derived: sum of 2 quarters · filed 2018-11-08 | $8.14M 10-Q · filed 2018-11-08 | $8.04M derived: sum of 4 quarters · filed 2019-03-01 | ||||||
| 2017-06-30 | $7.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $8.43M 10-Q · filed 2018-08-09 | $8.33M derived: sum of 3 quarters · filed 2019-03-01 | $8.28M derived: sum of 4 quarters · filed 2019-03-01 | ||||||
| 2017-03-31 | $771.00K 10-Q · filed 2018-05-10 | $671.00K derived: sum of 2 quarters · filed 2019-03-01 | $620.00K derived: sum of 3 quarters · filed 2019-03-01 | -$922.00K derived: sum of 4 quarters · filed 2019-03-01 | ||||||
| 2016-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$151.00K derived: sum of 2 quarters · filed 2019-03-01 | -$1.69M derived: sum of 3 quarters · filed 2019-03-01 | -$421.00K 10-K · filed 2019-03-01 | -$319.00K 10-K · filed 2017-03-16 | |||||
| 2016-09-30 | -$51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$1.59M derived: sum of 2 quarters · filed 2017-11-09 | -$321.00K 10-Q · filed 2017-11-09 | -$303.00K 10-Q · filed 2016-11-09 | $3.31M derived: sum of 4 quarters · filed 2018-03-01 | |||||
| 2016-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$270.00K 10-Q · filed 2017-08-08 | -$268.00K 10-Q · filed 2016-08-09 | $3.36M derived: sum of 3 quarters · filed 2018-03-01 | $5.31M derived: sum of 4 quarters · filed 2018-03-01 | |||||
| 2016-03-31 | $1.27M 10-Q · filed 2017-05-10 | $4.90M derived: sum of 2 quarters · filed 2018-03-01 | $6.85M derived: sum of 3 quarters · filed 2018-03-01 | $7.79M derived: sum of 4 quarters · filed 2018-03-01 | ||||||
| 2015-12-31 | $3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $5.58M derived: sum of 2 quarters · filed 2018-03-01 | $6.52M derived: sum of 3 quarters · filed 2018-03-01 | $4.35M 10-K · filed 2018-03-01 | $4.20M 10-K · filed 2016-03-15 | |||||
| 2015-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $2.89M derived: sum of 2 quarters · filed 2016-11-09 | $721.00K 10-Q · filed 2016-11-09 | $2.23M derived: sum of 4 quarters · filed 2017-03-16 | ||||||
| 2015-06-30 | $941.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$1.23M 10-Q · filed 2016-08-09 | $281.00K derived: sum of 3 quarters · filed 2017-03-16 | -$49.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||||
| 2015-03-31 | -$2.17M 10-Q · filed 2016-05-10 | -$1.94M 10-Q · filed 2015-05-11 | -$660.00K derived: sum of 2 quarters · filed 2017-03-16 | -$990.00K derived: sum of 3 quarters · filed 2017-03-16 | -$934.00K derived: sum of 4 quarters · filed 2017-03-16 | |||||
| 2014-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $1.18M derived: sum of 2 quarters · filed 2017-03-16 | $1.24M derived: sum of 3 quarters · filed 2017-03-16 | $5.46M 10-K · filed 2017-03-16 | ||||||
| 2014-09-30 | -$330.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$274.00K derived: sum of 2 quarters · filed 2015-11-09 | $3.95M 10-Q · filed 2015-11-09 | $2.33M derived: sum of 4 quarters · filed 2016-03-15 | ||||||
| 2014-06-30 | $56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $4.28M 10-Q · filed 2015-08-10 | $2.66M derived: sum of 3 quarters · filed 2016-03-15 | $2.11M derived: sum of 4 quarters · filed 2016-03-15 | ||||||
| 2014-03-31 | $4.22M 10-Q · filed 2015-05-11 | $3.96M 10-Q · filed 2014-05-12 | $2.60M derived: sum of 2 quarters · filed 2016-03-15 | $2.05M derived: sum of 3 quarters · filed 2016-03-15 | $1.83M derived: sum of 4 quarters · filed 2016-03-15 | |||||
| 2013-12-31 | -$1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$2.17M derived: sum of 2 quarters · filed 2016-03-15 | -$2.40M derived: sum of 3 quarters · filed 2016-03-15 | -$1.17M 10-K · filed 2016-03-15 | ||||||
| 2013-09-30 | -$548.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$774.00K derived: sum of 2 quarters · filed 2014-11-10 | $453.00K 10-Q · filed 2014-11-10 | -$1.25M derived: sum of 4 quarters · filed 2015-03-16 | ||||||
| 2013-06-30 | -$226.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $1.00M 10-Q · filed 2014-08-11 | -$703.00K derived: sum of 3 quarters · filed 2015-03-16 | $1.06M derived: sum of 4 quarters · filed 2015-03-16 | ||||||
| 2013-03-31 | $1.23M 10-Q · filed 2014-05-12 | -$477.00K derived: sum of 2 quarters · filed 2015-03-16 | $1.29M derived: sum of 3 quarters · filed 2015-03-16 | $880.00K derived: sum of 4 quarters · filed 2015-03-16 | ||||||
| 2012-12-31 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $60.00K derived: sum of 2 quarters · filed 2015-03-16 | -$347.00K derived: sum of 3 quarters · filed 2015-03-16 | -$2.00K 10-K · filed 2015-03-16 | $957.00K 10-K · filed 2013-03-18 | |||||
| 2012-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $1.36M derived: sum of 2 quarters · filed 2013-11-07 | $1.70M 10-Q · filed 2013-11-07 | $4.78M derived: sum of 4 quarters · filed 2014-03-13 | ||||||
| 2012-06-30 | -$407.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$62.00K 10-Q · filed 2013-08-09 | $3.01M derived: sum of 3 quarters · filed 2014-03-13 | $3.43M derived: sum of 4 quarters · filed 2014-03-13 | ||||||
| 2012-03-31 | $345.00K 10-Q · filed 2013-05-09 | $3.42M derived: sum of 2 quarters · filed 2014-03-13 | $3.84M derived: sum of 3 quarters · filed 2014-03-13 | $2.12M derived: sum of 4 quarters · filed 2014-03-13 | ||||||
| 2011-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $3.49M derived: sum of 2 quarters · filed 2014-03-13 | $1.77M derived: sum of 3 quarters · filed 2014-03-13 | $339.00K 10-K · filed 2014-03-13 | ||||||
| 2011-09-30 | $417.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$1.30M derived: sum of 2 quarters · filed 2012-11-09 | -$2.73M 10-Q · filed 2012-11-09 | -$672.00K derived: sum of 4 quarters · filed 2013-03-18 | $3.59M 10-Q · filed 2011-11-08 | |||||
| 2011-06-30 | -$1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$3.15M 10-Q · filed 2012-08-07 | -$1.09M derived: sum of 3 quarters · filed 2013-03-18 | -$532.00K derived: sum of 4 quarters · filed 2013-03-18 | $3.17M 10-Q · filed 2011-08-09 | |||||
| 2011-03-31 | -$1.44M 10-Q · filed 2012-05-10 | $627.00K derived: sum of 2 quarters · filed 2013-03-18 | $1.18M derived: sum of 3 quarters · filed 2013-03-18 | |||||||
| 2010-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $2.62M derived: sum of 2 quarters · filed 2013-03-18 | $1.46M 10-K · filed 2013-03-18 | |||||||
| 2010-09-30 | $557.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$601.00K 10-Q · filed 2011-11-08 | ||||||||
| 2010-06-30 | -$1.16M 10-Q · filed 2011-08-09 | |||||||||
| 2009-12-31 | $207.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |